Literature DB >> 2839686

Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection.

J A Hoxie1, B S Haggarty, S E Bonser, J L Rackowski, H Shan, P J Kanki.   

Abstract

We have analyzed a number of biological features of HTLV-IV, a retrovirus indistinguishable from a macaque isolate of simian immunodeficiency virus (SIV), and compared this virus with several strains of human immunodeficiency virus type 1 (HIV-1). Although HTLV-IV was found to be similar to HIV-1 in its tropism for CD4+ lymphocytes, its effects on CD4 expression and the ability of its externalized envelope molecule to form a complex directly with the CD4 molecule, a number of striking differences were noted. Unlike with HIV-1, the range of cells susceptible to HTLV-IV infection and syncytia formation was restricted to a subset of CD4+ cell lines, particularly those that coexpressed CD4 with human leukocyte antigen (HLA) class II antigens. An analysis of the patterns of HTLV-IV infection with B x T somatic cell hybrids indicated that for this virus, molecules in addition to CD4 were probably required to facilitate infection and cell fusion. Additional studies of HTLV-IV infection of Sup-T1 cells, which are exquisitely sensitive to cytopathic effects induced by HIV-1, demonstrated that HTLV-IV infection could occur in the absence of cytopathic effects and, remarkably, with minimal or no downmodulation of the CD4 molecule from the cell surface. The failure of HTLV-IV infection to reduce the expression of several CD4 epitopes suggested that the HTLV-IV envelope produced by Sup-T1 cells was altered in its ability to interact with or bind to CD4. Additional differences were also noted in the size of the transmembrane envelope molecule of HTLV-IV produced by Sup-T1 cells, indicating that cell-specific alterations in processing of the HTLV-IV envelope occurred during the production of virus in this cell line. Understanding the basis for these biological differences between HTLV-IV and the HIV-1 viruses may help to elucidate more general mechanisms for pathogenesis of other members of the SIV and HIV families of retroviruses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839686      PMCID: PMC253685          DOI: 10.1128/JVI.62.8.2557-2568.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Infection of T4 lymphocytes by HTLV-III does not require expression of the OKT4 epitope.

Authors:  J A Hoxie; L E Flaherty; B S Haggarty; J L Rackowski
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

2.  New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

Authors:  P J Kanki; F Barin; S M'Boup; J S Allan; J L Romet-Lemonne; R Marlink; M F McLane; T H Lee; B Arbeille; F Denis
Journal:  Science       Date:  1986-04-11       Impact factor: 47.728

3.  Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.

Authors:  J S McDougal; M S Kennedy; J M Sligh; S P Cort; A Mawle; J K Nicholson
Journal:  Science       Date:  1986-01-24       Impact factor: 47.728

4.  Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

Authors:  B H Hahn; G M Shaw; M E Taylor; R R Redfield; P D Markham; S Z Salahuddin; F Wong-Staal; R C Gallo; E S Parks; W P Parks
Journal:  Science       Date:  1986-06-20       Impact factor: 47.728

5.  Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys.

Authors:  M Murphey-Corb; L N Martin; S R Rangan; G B Baskin; B J Gormus; R H Wolf; W A Andes; M West; R C Montelaro
Journal:  Nature       Date:  1986 May 22-28       Impact factor: 49.962

6.  AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen.

Authors:  J D Lifson; G R Reyes; M S McGrath; B S Stein; E G Engleman
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

7.  Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys).

Authors:  P N Fultz; H M McClure; D C Anderson; R B Swenson; R Anand; A Srinivasan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa.

Authors:  F Barin; S M'Boup; F Denis; P Kanki; J S Allan; T H Lee; M Essex
Journal:  Lancet       Date:  1985 Dec 21-28       Impact factor: 79.321

9.  In vitro growth characteristics of simian T-lymphotropic virus type III.

Authors:  M Kannagi; J M Yetz; N L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys.

Authors:  P J Kanki; J Alroy; M Essex
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

View more
  40 in total

1.  Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge.

Authors:  P R Johnson; D C Montefiori; S Goldstein; T E Hamm; J Zhou; S Kitov; N L Haigwood; L Misher; W T London; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  Species-specific diversity among simian immunodeficiency viruses from African green monkeys.

Authors:  J S Allan; M Short; M E Taylor; S Su; V M Hirsch; P R Johnson; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Isolation from African Sykes' monkeys (Cercopithecus mitis) of a lentivirus related to human and simian immunodeficiency viruses.

Authors:  P Emau; H M McClure; M Isahakia; J G Else; P N Fultz
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

4.  Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4.

Authors:  M Ivey-Hoyle; J S Culp; M A Chaikin; B D Hellmig; T J Matthews; R W Sweet; M Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

5.  Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells.

Authors:  P A Ashorn; E A Berger; B Moss
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

6.  Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

Authors:  C J Miller; M B McChesney; X Lü; P J Dailey; C Chutkowski; D Lu; P Brosio; B Roberts; Y Lu
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques.

Authors:  Y Lu; P Brosio; M Lafaile; J Li; R G Collman; J Sodroski; C J Miller
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

8.  Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion.

Authors:  S Koenig; V M Hirsch; R A Olmsted; D Powell; W Maury; A Rabson; A S Fauci; R H Purcell; P R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus.

Authors:  L Bergeron; N Sullivan; J Sodroski
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac.

Authors:  B Banapour; M L Marthas; R A Ramos; B L Lohman; R E Unger; M B Gardner; N C Pedersen; P A Luciw
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.